logo-loader
Astrid Intelligence PLC

Cellular Goods PLC - Update on ingestibles product range

RNS Number : 1909I
Cellular Goods PLC
13 April 2022
 

The information contained within this announcement is deemed by the Company to constitute inside

information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of

the law of England and Wales. Upon the publication of this announcement via the Regulatory

Information Service, this inside information is now considered to be in the public domain.

 

 

Press release

 

13 April 2022

 

Cellular Goods PLC

 

('Cellular Goods' or 'the Company')

 

Update on ingestibles product range

 

Further to the announcement of 11 April 2022, the Company provides an update concerning its communications with the Food Standards Authority ("FSA") with regards to its ingestibles range.

 

The FSA's current position is that any new products not on sale before February 2020 are not eligible for the public list and therefore should not be available for sale. As announced previously, the Company's branded products are manufactured and supplied by Chanelle McCoy Health ("CMH"), whose products are validated and included on the FSA's permitted list published on 31 March 2022.

 

Cellular Goods is currently considering its position pending advice from the company's advisers and is also seeking further clarification on the FSA's stance, considering that these products are identical to the validated products from CMH. The Company's skincare range, which accounts for the bulk of its overall sales, remains unaffected.

 

For further information please contact:

Cellular Goods


Anna Chokina

Chief Executive

Neil Thapar

Investor Relations

via Tancredi +44 207 887 7633

 

+44 787 645 5323

Tennyson Securities


Corporate Broker

Peter Krens

 

+44 207 186 9030

Novum Securities


Corporate Broker

Colin Rowbury

Jon Belliss

 

 

+44 207 399 9427 

Tancredi Intelligent Communication


Media Relations

Helen Humphrey

Gabriela Amaya Garcia

Charlie Hobbs

cellulargoods@tancredigroup.com

 

+44 744 922 6720

+44 791 503 5294

+44 789 755 7112

 

About Cellular Goods PLC:

Cellular Goods is a UK-based wellness company that provides premium products based on lab-made cannabinoids. It was established in August 2018 to develop efficacy-led and research-backed cannabinoid-powered wellness products. The initial focus is on three product verticals: Function Better, Feel Better and Look Better. These three verticals encompass Cellular Goods' premium CBG skincare and CBD ingestible and topical athletic recovery products, with the first products launched in December 2021 initially through the Company's website. The Company's shares are listed on the main market of the London Stock Exchange. www.cellular-goods.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFSESEEESELL
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Anglo Asian Mining, Thor Explorations, Poolbeg, Astrid Intelligence, QBT,...

Anglo Asian Mining Plc (LSE:AAZ, OTC:AGXKF, FRA:A4A) saw copper production surge almost sevenfold in Q1, driven by its Demirli mine in Azerbaijan. Cash rose to $37 million and the company is now in a net cash position. Read more Thor Explorations Ltd (TSX-V:THX, AIM:THX, OTC:THXPF, FRA:T2X)...

on 04/15/2026

3 min read